Can Prostate Cancer Really Respond to Immunotherapy?

被引：3

作者：

Kim, Won ^{[1
]}

Fong, Lawrence ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 01期

关键词：

CELL LUNG-CANCER; ELM-PC; 5; UNTREATED MELANOMA; DOUBLE-BLIND; NIVOLUMAB; DOCETAXEL; IPILIMUMAB; TRIAL; CHEMOTHERAPY; MULTICENTER;

D O I：

10.1200/JCO.2016.70.4791

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4 / +

页数：3

共 22 条

[1] Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095
[2] Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
Beer, Tomasz M.
Kwon, Eugene D.
Drake, Charles G.
Fizazi, Karim
Logothetis, Christopher
Gravis, Gwenaelle
Ganju, Vinod
Polikoff, Jonathan
Saad, Fred
Humanski, Piotr
Piulats, Josep M.
Gonzalez Mella, Pablo
Ng, Siobhan S.
Jaeger, Dirk
Parnis, Francis X.
Franke, Fabio A.
Puente, Javier
Carvajal, Roman
Sengelov, Lisa
McHenry, M. Brent
Varma, Arvind
van den Eertwegh, Alfonsus J.
Gerritsen, Winald
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (01) : 40 - +
[3] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
Borghaei, H.
Paz-Ares, L.
Horn, L.
Spigel, D. R.
Steins, M.
Ready, N. E.
Chow, L. Q.
Vokes, E. E.
Felip, E.
Holgado, E.
Barlesi, F.
Kohlhaeufl, M.
Arrieta, O.
Burgio, M. A.
Fayette, J.
Lena, H.
Poddubskaya, E.
Gerber, D. E.
Gettinger, S. N.
Rudin, C. M.
Rizvi, N.
Crino, L.
Blumenschein, G. R.
Antonia, S. J.
Dorange, C.
Harbison, C. T.
Finckenstein, F. Graf
Brahmer, J. R.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) : 1627 - 1639
[4] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Brahmer, Julie
Reckamp, Karen L.
Baas, Paul
Crino, Lucio
Eberhardt, Wilfried E. E.
Poddubskaya, Elena
Antonia, Scott
Pluzanski, Adam
Vokes, Everett E.
Holgado, Esther
Waterhouse, David
Ready, Neal
Gainor, Justin
Aren Frontera, Osvaldo
Havel, Libor
Steins, Martin
Garassino, Marina C.
Aerts, Joachim G.
Domine, Manuel
Paz-Ares, Luis
Reck, Martin
Baudelet, Christine
Harbison, Christopher T.
Lestini, Brian
Spigel, David R.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) : 123 - 135
[5] Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
de Bono, Johann Sebastian
Oudard, Stephane
Ozguroglu, Mustafa
Hansen, Steinbjorn
Machiels, Jean-Pascal
Kocak, Ivo
Gravis, Gwenaelle
Bodrogi, Istvan
Mackenzie, Mary J.
Shen, Liji
Roessner, Martin
Gupta, Sunil
Sartor, A. Oliver
[J]. LANCET, 2010, 376 (9747) : 1147 - 1154
[6] Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or After Docetaxel-Based Therapy: ELM-PC 5
Fizazi, Karim
Jones, Robert
Oudard, Stephane
Efstathiou, Eleni
Saad, Fred
de Wit, Ronald
De Bono, Johann
Cruz, Felipe Melo
Fountzilas, George
Ulys, Albertas
Carcano, Flavio
Agarwal, Neeraj
Agus, David
Bellmunt, Joaquim
Petrylak, Daniel P.
Lee, Shih-Yuan
Webb, Iain J.
Tejura, Bindu
Borgstein, Niels
Dreicer, Robert
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07) : 723 - 731
[7] Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer
Fong, Lawrence
Carroll, Peter
Weinberg, Vivian
Chan, Stephen
Lewis, Jera
Corman, John
Amling, Christopher L.
Stephenson, Robert A.
Simko, Jeffrey
Sheikh, Nadeem A.
Sims, Robert B.
Frohlich, Mark W.
Small, Eric J.
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (11):
[8] Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF
Fong, Lawrence
Kwek, Serena S.
O'Brien, Shaun
Kavanagh, Brian
McNeel, Douglas G.
Weinberg, Vivian
Lin, Amy M.
Rosenberg, Jonathan
Ryan, Charles J.
Rini, Brian I.
Small, Eric J.
[J]. CANCER RESEARCH, 2009, 69 (02) : 609 - 615
[9] Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer
Graff, Julie N.
Alumkal, Joshi J.
Drake, Charles G.
Thomas, George V.
Redmond, William L.
Farhad, Mohammad
Cetnar, Jeremy P.
Ey, Frederick S.
Bergan, Raymond C.
Slottke, Rachel
Beer, Tomasz M.
[J]. ONCOTARGET, 2016, 7 (33) : 52810 - 52817
[10] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. Stephen
O'Day, Steven J.
McDermott, David F.
Weber, Robert W.
Sosman, Jeffrey A.
Haanen, John B.
Gonzalez, Rene
Robert, Caroline
Schadendorf, Dirk
Hassel, Jessica C.
Akerley, Wallace
van den Eertwegh, Alfons J. M.
Lutzky, Jose
Lorigan, Paul
Vaubel, Julia M.
Linette, Gerald P.
Hogg, David
Ottensmeier, Christian H.
Lebbe, Celeste
Peschel, Christian
Quirt, Ian
Clark, Joseph I.
Wolchok, Jedd D.
Weber, Jeffrey S.
Tian, Jason
Yellin, Michael J.
Nichol, Geoffrey M.
Hoos, Axel
Urba, Walter J.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) : 711 - 723

← 1 2 3 →